Clincosm LogoSign in Get a demo

Evaluation of Patient's Knowledge of Their NACO Treatment

Sponsor
Groupe Hospitalier Paris Saint Joseph (Other)
Overall Status
Completed
CT.gov ID
NCT03323320
Collaborator
(none)
51
Enrollment
1
Location
10.9
Actual Duration (Months)
4.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant .

The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    51 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Evaluation of Patient's Knowledge of Their NACO Treatment
    Actual Study Start Date :
    Dec 5, 2016
    Actual Primary Completion Date :
    Mar 31, 2017
    Actual Study Completion Date :
    Nov 1, 2017

    Outcome Measures

    Primary Outcome Measures

    1. questionnaire score >80% [Day 1]

      it's a questionnaire about anticoagulant treatment ; each question has a score ans for the study investigators calculate the total

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • patient with AOD treatment

    • capable to answer to questionnaire

    • with or without antivitamin K

    Exclusion Criteria:

    • dementia

    • cognitive trouble

    • refusing participation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France France 75014

    Sponsors and Collaborators

    • Groupe Hospitalier Paris Saint Joseph

    Investigators

    • Study Director: Romain CADOR, MD, GHPSJ

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Groupe Hospitalier Paris Saint Joseph
    ClinicalTrials.gov Identifier:
    NCT03323320
    Other Study ID Numbers:
    • AOD
    First Posted:
    Oct 27, 2017
    Last Update Posted:
    Feb 27, 2018
    Last Verified:
    Feb 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Feb 27, 2018